![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: DPH2 |
Gene summary for DPH2 |
![]() |
Gene information | Species | Human | Gene symbol | DPH2 | Gene ID | 1802 |
Gene name | diphthamide biosynthesis 2 | |
Gene Alias | DPH2L2 | |
Cytomap | 1p34.1 | |
Gene Type | protein-coding | GO ID | GO:0002181 | UniProtAcc | Q9BQC3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1802 | DPH2 | LP15 | Human | Oral cavity | LP | 4.58e-04 | 4.81e-01 | 0.2174 |
1802 | DPH2 | LP17 | Human | Oral cavity | LP | 8.07e-08 | 4.17e-01 | 0.2349 |
1802 | DPH2 | SYSMH1 | Human | Oral cavity | OSCC | 2.32e-03 | 1.17e-01 | 0.1127 |
1802 | DPH2 | SYSMH2 | Human | Oral cavity | OSCC | 8.56e-12 | 2.80e-01 | 0.2326 |
1802 | DPH2 | SYSMH3 | Human | Oral cavity | OSCC | 3.93e-23 | 5.55e-01 | 0.2442 |
1802 | DPH2 | SYSMH5 | Human | Oral cavity | OSCC | 4.36e-05 | 1.51e-01 | 0.0647 |
1802 | DPH2 | P1_cSCC | Human | Skin | cSCC | 2.69e-03 | 3.08e-01 | 0.0292 |
1802 | DPH2 | P2_cSCC | Human | Skin | cSCC | 1.87e-03 | 2.72e-01 | -0.024 |
1802 | DPH2 | P4_cSCC | Human | Skin | cSCC | 1.92e-07 | 3.27e-01 | -0.00290000000000005 |
1802 | DPH2 | P10_cSCC | Human | Skin | cSCC | 1.03e-03 | 2.99e-01 | 0.1017 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0002181111 | Esophagus | ESCC | cytoplasmic translation | 135/8552 | 148/18723 | 4.17e-32 | 2.65e-29 | 135 |
GO:0006417111 | Esophagus | ESCC | regulation of translation | 304/8552 | 468/18723 | 1.53e-17 | 1.33e-15 | 304 |
GO:000641419 | Esophagus | ESCC | translational elongation | 41/8552 | 55/18723 | 1.26e-05 | 1.16e-04 | 41 |
GO:000218122 | Liver | HCC | cytoplasmic translation | 132/7958 | 148/18723 | 9.09e-33 | 5.76e-30 | 132 |
GO:000641722 | Liver | HCC | regulation of translation | 287/7958 | 468/18723 | 8.79e-17 | 8.08e-15 | 287 |
GO:000641412 | Liver | HCC | translational elongation | 36/7958 | 55/18723 | 4.94e-04 | 3.23e-03 | 36 |
GO:000218120 | Oral cavity | OSCC | cytoplasmic translation | 133/7305 | 148/18723 | 1.94e-38 | 2.46e-35 | 133 |
GO:000641720 | Oral cavity | OSCC | regulation of translation | 274/7305 | 468/18723 | 4.39e-18 | 4.63e-16 | 274 |
GO:000641416 | Oral cavity | OSCC | translational elongation | 37/7305 | 55/18723 | 2.03e-05 | 1.94e-04 | 37 |
GO:0002181110 | Oral cavity | LP | cytoplasmic translation | 124/4623 | 148/18723 | 5.09e-52 | 3.19e-48 | 124 |
GO:0006417110 | Oral cavity | LP | regulation of translation | 175/4623 | 468/18723 | 4.49e-10 | 2.22e-08 | 175 |
GO:000641417 | Oral cavity | LP | translational elongation | 25/4623 | 55/18723 | 6.27e-04 | 5.71e-03 | 25 |
GO:000218129 | Skin | cSCC | cytoplasmic translation | 127/4864 | 148/18723 | 4.83e-53 | 7.57e-50 | 127 |
GO:000641729 | Skin | cSCC | regulation of translation | 226/4864 | 468/18723 | 8.78e-26 | 2.62e-23 | 226 |
GO:000641423 | Skin | cSCC | translational elongation | 30/4864 | 55/18723 | 6.13e-06 | 8.70e-05 | 30 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DPH2 | SNV | Missense_Mutation | c.320N>A | p.Gly107Asp | p.G107D | Q9BQC3 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AR-A255-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Targeted Molecular therapy | trastuzumab | SD | |
DPH2 | insertion | Nonsense_Mutation | novel | c.1070_1071insAGCCCTGACCCAGACCTTGACCCAGACCTGAGTCGGCTGCTCT | p.Ile358AlafsTer10 | p.I358Afs*10 | Q9BQC3 | protein_coding | TCGA-A8-A07R-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Ancillary | zoledronic | SD | ||
DPH2 | insertion | In_Frame_Ins | novel | c.202_203insCATCCCTCCCTTCCACCTACTACGTGGGGCAGA | p.Ala67_Arg68insProSerLeuProSerThrTyrTyrValGlyGln | p.A67_R68insPSLPSTYYVGQ | Q9BQC3 | protein_coding | TCGA-AO-A03L-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | cyclophosphamide | SD | ||
DPH2 | SNV | Missense_Mutation | c.637N>C | p.Glu213Gln | p.E213Q | Q9BQC3 | protein_coding | deleterious(0.01) | possibly_damaging(0.492) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
DPH2 | SNV | Missense_Mutation | novel | c.535N>G | p.Ser179Gly | p.S179G | Q9BQC3 | protein_coding | tolerated(0.24) | benign(0.122) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
DPH2 | SNV | Missense_Mutation | novel | c.687N>G | p.Asp229Glu | p.D229E | Q9BQC3 | protein_coding | tolerated(0.45) | benign(0.007) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
DPH2 | SNV | Missense_Mutation | novel | c.1067N>T | p.Gln356Leu | p.Q356L | Q9BQC3 | protein_coding | deleterious(0) | benign(0.023) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
DPH2 | SNV | Missense_Mutation | rs750812731 | c.910C>T | p.Arg304Trp | p.R304W | Q9BQC3 | protein_coding | deleterious(0) | possibly_damaging(0.745) | TCGA-CM-4746-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
DPH2 | SNV | Missense_Mutation | c.1216G>A | p.Glu406Lys | p.E406K | Q9BQC3 | protein_coding | tolerated(0.07) | benign(0.037) | TCGA-D5-6531-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
DPH2 | SNV | Missense_Mutation | rs760454990 | c.1444N>A | p.Ala482Thr | p.A482T | Q9BQC3 | protein_coding | deleterious(0.01) | probably_damaging(0.916) | TCGA-D5-6540-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |